# 50 Questions & Answers for Judges
**Project: Cognitive Performance Trend Analysis Tool**

This document contains 50 potential questions judges might ask, along with suggested answers based on the project's architecture, ethical guidelines, and technical implementation.

---

## 🔹 Problem & Solution (The "Why")

**1. Q: What is the core problem your application solves?**
**A:** We address the lack of accessible, continuous monitoring for cognitive health. Most cognitive testing happens only *after* symptoms appear; our tool enables proactive, longitudinal tracking to detect subtle trend changes early.

**2. Q: How is this different from existing brain training games (like Lumosity)?**
**A:** Unlike games designed for entertainment or "training," our focus is on **biometric trend analysis**. We don't just give a score; we analyze the *slope* of performance over time to distinguish between normal fluctuations and meaningful decline.

**3. Q: Who is your target audience?**
**A:** Primarily individuals with a family history of cognitive decline who want to establish a baseline, as well as the "worried well" population seeking reassurance through objective data.

**4. Q: Is this a medical device?**
**A:** No. This is a **health awareness and monitoring tool**, not a diagnostic device. It provides data to facilitate conversations with healthcare providers, not to replace them.

**5. Q: What inspired this specific approach?**
**A:** The realization that isolated doctor visits miss the "day-to-day" picture. We wanted to create something that captures the *long-term trend* of a user's cognitive health in a low-stress environment.

---

## 🔹 Technical Implementation (The "How")

**6. Q: What tech stack did you use and why?**
**A:** We used **React and TypeScript** for the frontend to ensure type safety and a responsive UI. For the analysis, we implemented custom algorithms in TypeScript to run locally in the browser, ensuring data privacy.

**7. Q: How do you handle data persistence?**
**A:** Currently, we use `localStorage` for privacy preservation and ease of prototyping. This ensures data stays on the user's device. We have architecture in place to migrate to a secure cloud solution (like Firebase) for cross-device synchronization.

**8. Q: Why did you choose to build this as a web app instead of a native mobile app?**
**A:** Accessibility. A web app allows anyone with a browser (desktop or mobile) to use the tool without friction steps like downloading an app, which is crucial for our older target demographic.

**9. Q: How do you ensure the application is accessible for older adults?**
**A:** We followed strict accessibility guidelines: high-contrast text, large touch targets, clear instructions, and a "clinical-calm" design aesthetic that avoids overstimulating animations.

**10. Q: Describe the architecture of your application.**
**A:** It follows a component-based architecture. Key modules include the **Assessment Engine** (handles the tests), **Feature Extractor** (raw data to metrics), **Trend Analyzer** (calculates slopes), and the **Dashboard** (visualization).

**11. Q: How do you handle state management?**
**A:** We use React's built-in hooks/Context API for local state management, as the data flow is unidirectional (Test -> Results -> Dashboard).

**12. Q: Did you use any external libraries for the charts?**
**A:** Yes, we used [Chart.js / Recharts] (verify in code) to render the trend lines, but the data *feeding* the charts is processed by our custom analysis engine.

**13. Q: How modular is your code? Can you add new tests easily?**
**A:** Highly modular. The `Assessment` component is designed to be plug-and-play. We can add a new test type (e.g., "spatial reasoning") just by creating a new component and defining its feature extraction logic.

**14. Q: What was the biggest technical challenge you faced?**
**A:** Normalizing data across different sessions. Since users might take tests at irregular intervals, we had to implement a time-normalization algorithm to calculate accurate trend slopes based on timestamps, not just session IDs.

**15. Q: How does the application perform on slow networks?**
**A:** Since the logic runs client-side, once the app loads, it works entirely offline. This is a key feature for reliability.

---

## 🔹 AI & Algorithms (The "Brain")

**16. Q: How do you calculate the "Trend Slope"?**
**A:** We use **linear regression** on normalized timestamps. We calculate the slope ($m$) of the line of best fit for metrics like reaction time and memory accuracy. A positive slope in accuracy or negative slope in reaction time indicates improvement.

**17. Q: What features are you extracting from the raw test data?**
**A:** We extract `memoryAccuracy`, `reactionTimeAvg`, `patternScore`, and `lexicalDiversity`. These are aggregated into a session vector for analysis.

**18. Q: How do you determine the "Overall Trend Direction"?**
**A:** We average the slopes of individual metrics and apply a `tanh` (hyperbolic tangent) transformation to normalize the result between -1 (Decline) and 1 (Improvement).

**19. Q: What is the "Confidence Score" based on?**
**A:** It's primarily based on the **volume and consistency of data**. A user with 2 data points has low confidence; a user with 20 points over a month has high confidence.

**20. Q: Do you use any Machine Learning models?**
**A:** Currently, we use statistical regression (which is the foundation of ML). We are collecting structured data that can train more complex predictive models (like Random Forest or LSTM) in the future to detect non-linear decline patterns.

**21. Q: How do you handle outliers (e.g., user was just distracted)?**
**A:** Our slope calculation uses all available points, but the "Consistency" metric helps identify noisy data. Future versions will implement RANSAC or similar robust regression techniques to ignore outliers.

**22. Q: Can the algorithm distinguish between "bad day" and "decline"?**
**A:** Yes, that's why we focus on **longitudinal trends**. A single low score affects the average but doesn't drastically change the long-term slope unless it becomes a consistent pattern.

**23. Q: Why did you choose Lexical Diversity as a metric?**
**A:** Research shows that vocabulary reduction is often one of the earliest signs of cognitive decline (e.g., in Alzheimer's), often appearing before memory loss.

**24. Q: How do you normalize reaction time data?**
**A:** We look at the *change* relative to the user's personal baseline. We don't compare a 70-year-old to a 20-year-old; we compare the 70-year-old to themselves last month.

**25. Q: Is your algorithm biased?**
**A:** By using **intra-individual variability** (comparing you to you), we remove biases related to age, gender, education, or tech-savviness that often plague standardized cognitive tests.

---

## 🔹 Medical Validity & Science

**26. Q: What scientific basis do these tests have?**
**A:** Our tests are digital adaptations of validated clinical instruments: the "n-back" task for working memory and "reaction time tasks" (PVT) for psychomotor speed.

**27. Q: How do you define "Stable" vs. "Risk"?**
**A:** "Stable" means the trend slope is near zero. "Risk" is triggered when the negative slope exceeds a specific threshold (e.g., >0.5 deviations) compounded over multiple sessions.

**28. Q: Can stress or fatigue affect the results?**
**A:** Absolutely. That's why we prompt users to record their mood/sleep state before testing. We plan to use this as a covariate in our analysis to filter out "fatigue noise."

**29. Q: Why did you include a Pattern Recognition test?**
**A:** It assesses **fluid intelligence** and executive function—the ability to learn new rules—which is distinct from simple memory recall.

**30. Q: Have you validated this with real doctors?**
**A:** (Honest answer): We have designed it based on published medical literature (cite papers if possible), but clinical validation would be the next step in our roadmap.

**31. Q: What happens if a user improves? (Practice Effect)**
**A:** We expect a "Practice Effect" initially. Our algorithm looks for the *plateau* followed by a decline. Improvement is normal; specific patterns of post-plateau decline are what we monitor for.

**32. Q: Did you consult any medical professionals during the design?**
**A:** (If applicable) Yes, we spoke to [X]. (If not): We relied on research from the Journal of Alzheimer's Disease and standard cognitive assessment protocols.

**33. Q: How does this help a doctor?**
**A:** It provides strictly objective longitudinal data. Instead of a patient saying "I feel forgetful lately," they can show a 3-month graph showing a 15% increase in reaction latency.

**34. Q: Why focus on reaction time?**
**A:** It is one of the most robust biomarkers for general CNS (Central Nervous System) integrity and often slows down significantly in prodromal stages of neurodegeneration.

**35. Q: Are the tests randomized?**
**A:** Yes. To prevent users from memorizing answers (which would invalidate the test), all patterns and sequences are procedurally generated every session.

---

## 🔹 Ethics, Privacy & Safety

**36. Q: What if you give someone a false positive and panic them?**
**A:** We have a strict **"Anti-Anxiety" wording policy**. We never use words like "Disease" or "Diagnosis." We only report "Trends" and "Changes," framing them as cues to check in with a doctor, not medical verdicts.

**37. Q: How do you protect user privacy?**
**A:** Data is stored locally. We do not require an account or email to start. The user owns their data entirely and can "Wipe Data" at any time.

**38. Q: What happens if the AI detects a severe decline?**
**A:** The app displays a supportive message suggesting a professional consultation for a "comprehensive check-up," avoiding alarmist language.

**39. Q: Are you HIPPA compliant?**
**A:** Currently, as a local tool without cloud storage, we fall outside HIPAA scope. However, our roadmap includes full encryption and HIPAA compliance before any cloud features are added.

**40. Q: Is there an ethical capability for a family member to "spy" on a user?**
**A:** We designed the UI to be user-centric. While a family member *could* look, the tool is designed to empower the individual. We do not have "remote monitoring" features that would violate user autonomy.

**41. Q: How do you handle the "labeling" effect?**
**A:** We avoid labels. We use colors (Green/Amber) and neutral terms ("Stable", "Variation") to prevent the user from internalizing a "sick role."

**42. Q: What if the user is physically unable to use the screen (tremors)?**
**A:** We have large touch targets, but we acknowledge this is a limitation. Future versions will support voice-only interactions to accommodate motor impairments.

**43. Q: How transparent is the AI?**
**A:** Completely. We show the graphs. We don't give a "Black Box" score; we show the actual trend line so the user can see *why* the system says what it says.

**44. Q: What did you do to ensure the design isn't depressing?**
**A:** We used a color palette that is professional yet warm, avoiding "hospital sterile" white or "danger" red. We focus on "maintaining health" rather than "detecting disease."

**45. Q: Do you sell user data?**
**A:** Absolutely not. Our business model (if we had one) would be subscription-based or B2B with clinics, never ad-based or data-selling.

---

## 🔹 Future & Business Validity

**46. Q: How would you monetize this?**
**A:** A "Freemium" model. Basic monitoring is free. Premium features (export to PDF for doctors, deeper analytics, family sharing) could be a subscription. Alternatively, licensing to insurance companies as a preventative tool.

**47. Q: What is the biggest limitation of your current prototype?**
**A:** The lack of long-term data. To truly validate the slope algorithm, we need months of user data. We currently simulate this for demonstration.

**48. Q: How does this scale to 1 million users?**
**A:** The processing is **Edge/Client-side**. The server costs would be minimal since the heavy lifting (trend analysis) happens on the user's device. We just store small JSON blobs. Scaling would be very efficient.

**49. Q: What feature would you add next if you had more time?**
**A:** Voice biomarkers. Analyzing speech patterns (pauses, filler words) during a "describe this image" task, which is a powerful cognitive indicator.

**50. Q: Why should we pick your team?**
**A:** Because we balanced **technical innovation** (custom trend algorithms) with **human-centric design** (ethics, accessibility). We didn't just build a calculator; we built a tool that understands the human weight of the problem it solves.
